Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-14

Clinical Trial Update: Rapid Sequence Induction: Succinyl Choline vs Rocuronium After Pretreatment With Dexmedetomidine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing succinyl choline versus rocuronium for rapid sequence induction after pretreatment with dexmedetomidine; status not disclosed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Rocuronium (rocuronium bromide)
  • Succinyl choline (succinylcholine)

Snippet

Sponsor: South Valley University | Conditions: Rapid Sequence Induction | Phase 3 | Status: UNKNOWN